| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8310148 | Clinica Chimica Acta | 2016 | 7 Pages |
Abstract
Gal-3 is not able to distinguish between HFrEF and HFpEF patients. However it is related to diastolic dysfunction severity and LV stiffness in HFpEF. Gal-3 demonstrates a prognostic role independently from renal dysfunction in subjects with HFpEF.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Matteo Beltrami, Gaetano Ruocco, Amardeep Ghosh Dastidar, Beatrice Franci, Barbara Lucani, Elio Aloia, Ranuccio Nuti, Alberto Palazzuoli,